The protective effect of erinacine A-enriched Hericium erinaceus mycelium ethanol extract on oxidative Stress-Induced neurotoxicity in cell and Drosophila models of spinocerebellar ataxia type 3.
暂无分享,去创建一个
Wei-Yong Lin | Haw‐Wen Chen | Yu-Ling Wu | Kai-Li Liu | Shiuan-Chih Chen | Jui-Chih Chang | Chien‐Chun Li | M. Hsieh | T. Chang | Chinde Chen | Chin-San Liu
[1] G. Ciofani,et al. Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases , 2022, ACS omega.
[2] Pooja Mittal,et al. Fungal Mushrooms: A Natural Compound With Therapeutic Applications , 2022, Frontiers in Pharmacology.
[3] Guan Wang,et al. Deconvoluting the Complexity of Reactive Oxygen Species (ROS) in Neurodegenerative Diseases , 2022, Frontiers in Neuroanatomy.
[4] Manho Kim,et al. Therapeutic potential of ginsenoside Rg3 and Rf for Huntington’s disease , 2021, In Vitro Cellular & Developmental Biology - Animal.
[5] V. Pérez,et al. Aggresome-Like Formation Promotes Resistance to Proteotoxicity in Cells from Long-Lived Species. , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.
[6] T. G. Singh,et al. Role of Nuclear Factor Kappa B (NF-KB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach , 2020, Current neuropharmacology.
[7] P. Maciel,et al. From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation , 2019, Neurotherapeutics.
[8] M. Saraiva-Pereira,et al. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[9] M. Cvetanovic,et al. Inhibition of NF-κB signaling in IKKβF/F;LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1 , 2018, PloS one.
[10] Yen-Po Chen,et al. Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines , 2018, Behavioural neurology.
[11] Wei-Yong Lin,et al. Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway , 2018, Free radical biology & medicine.
[12] M. França,et al. Clinical Features of Machado-Joseph Disease. , 2018, Advances in experimental medicine and biology.
[13] D. Souza,et al. Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease , 2017, Front. Neurol..
[14] Wei-Yong Lin,et al. Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3 , 2017, Scientific Reports.
[15] A. Szybińska,et al. P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes? , 2017, Aging and disease.
[16] Haw‐Wen Chen,et al. Borage oil supplementation decreases lipopolysaccharide-induced inflammation and skeletal muscle wasting in mice , 2016 .
[17] M. Friedman. Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. , 2015, Journal of agricultural and food chemistry.
[18] Yueh-Ting Tsai,et al. Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium , 2014, Toxicology reports.
[19] Yueh-Ting Tsai,et al. Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[20] S. Pulst,et al. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. , 2014, Brain : a journal of neurology.
[21] L. Borza. A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases. , 2014, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.
[22] Ü. Langel,et al. Inhibition of Autophagy via p53-Mediated Disruption of ULK1 in a SCA7 Polyglutamine Disease Model , 2013, Journal of Molecular Neuroscience.
[23] N. Bhattacharyya,et al. Regulation of miR-146a by RelA/NFkB and p53 in STHdhQ111/HdhQ111 Cells, a Cell Model of Huntington's Disease , 2011, PloS one.
[24] T. Klockgether,et al. FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. , 2011, Human molecular genetics.
[25] Ju-Yu Chen,et al. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons , 2011, Neurochemistry International.
[26] T. Yeh,et al. Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons , 2010, Experimental Neurology.
[27] I. Dimauro,et al. AlphaB-crystallin is involved in oxidative stress protection determined by VEGF in skeletal myoblasts. , 2010, Free radical biology & medicine.
[28] Martin J. Scanlon,et al. Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation , 2010, Proceedings of the National Academy of Sciences.
[29] N. Takei,et al. Downregulation of NF-κB signaling by mutant huntingtin proteins induces oxidative stress and cell death , 2010, Cellular and Molecular Life Sciences.
[30] C. Kuo,et al. Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado‐Joseph disease , 2009, Journal of neuroscience research.
[31] N. Nukina,et al. Decreased protein synthesis of Hsp27 associated with cellular toxicity in a cell model of Machado–Joseph disease , 2009, Neuroscience Letters.
[32] T. Yeh,et al. Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-kappaB p65 and impairs NF-kappaB activity by inhibiting proteasome activity of cerebellar neurons. , 2007, Cellular signalling.
[33] N. Nukina,et al. Expression of Expanded Polyglutamine Proteins Suppresses the Activation of Transcription Factor NFκB* , 2006, Journal of Biological Chemistry.
[34] S. Snyder,et al. p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.
[35] H. Kawagishi,et al. Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats , 2005 .
[36] Horng‐Jyh Tsai,et al. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells. , 2004, Biochemical and biophysical research communications.
[37] D. Rubinsztein,et al. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. , 2002, Human molecular genetics.